Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 113
Filtrar
1.
J Glob Infect Dis ; 10(3): 140-146, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30166813

RESUMEN

BACKGROUND AND OBJECTIVES: Discovered in 1983, Extended spectrum beta-lactamase (ESBL) producers are still the leading cause of infections in India. Its prompt detection is crucial to the clinical management. The Clinical Laboratory Standards Institute (CLSI) recommends phenotypic screening and confirmatory tests to identify the ESBL producer making it cost and time consuming for the diagnostic laboratory. We compare here the screening and confirmatory tests offering a solution to the CLSI recommendation. METHODS: Nosocomial isolates E. coli (71) and K. pneumoniae (25) resistant to cefotaxime and ceftazidime were included. CLSI recommended testing with cefotaxime, ceftazidime and in combination with clavulanic acid by disk diffusion and agar dilution methods were performed. E-test was performed on discrepant results. To determine the genetic relatedness of the organisms, 22 Medical and Surgical ICU isolates were genotyped by PFGE. Dendrogram was constructed using dice co-efficient, UPGMA method with diversity database software. RESULTS AND CONCLUSIONS: Phenotypic screening disk diffusion test versus the confirmatory agar dilution MIC tests with cefotaxime and ceftazidime correlated well with the final ESBL status (kappa 0.852 and 0.905 P < 0.001) and (kappa 0.911 and 0.822 P < 0.001). The tests show 99-100% sensitivity, 75-83.3% specificity, and positive likelihood ratios between 4.0 -5.9. E-test confirmed 6 of 12 discordant results as ESBLs. Of the 96 nosocomial isolates screened as possible ESBL producers by the Kirby-Bauer disk diffusion test, 86.5% were confirmed ESBL producers. Genotyping on the ICU isolates by PFGE revealed a genetically diverse population suggesting no transmission of phenotypically similar ESBL strains within the ICUs.

2.
Diagn Microbiol Infect Dis ; 80(4): 334-7, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25439447

RESUMEN

The prevalence, antimicrobial susceptibility, and genotypes of Streptococcus pneumoniae "putative serotype 6E" isolates from Asian countries were investigated. A total of 244 S. pneumoniae serogroup 6 isolates obtained from 11 Asian countries were included in this study. Of the 244 serogroup 6 isolates, 101 (41.4%) were typed as "putative serotype 6E," followed by serotypes 6A, 6B, 6C, and 6D (27.0, 20.1, 5.7, and 5.7%, respectively). Multilocus sequence typing revealed that clonal complex (CC) 90, including ST90 and its variants, was the most prevalent clonal group of "putative serotype 6E" isolates (n = 63; 62.4%). CC146 and CC315 were also found frequently in some of the countries. Most of the "putative serotype 6E" isolates showed very high resistance rates against cefuroxime, erythromycin, azithromycin, clarithromycin, clindamycin, and trimethoprim/sulfamethoxazole, probably due to their highly resistant to antimicrobials clone, CC90. Our results indicate that "putative serotype 6E" is prevalent in Asian countries. The clonal dissemination of "putative serotype 6E" isolates was also identified.


Asunto(s)
Farmacorresistencia Bacteriana/efectos de los fármacos , Infecciones Neumocócicas/microbiología , Streptococcus pneumoniae/efectos de los fármacos , Streptococcus pneumoniae/genética , Streptococcus pneumoniae/aislamiento & purificación , Antibacterianos/farmacología , Asia , Humanos , Pruebas de Sensibilidad Microbiana , Tipificación de Secuencias Multilocus , Infecciones Neumocócicas/epidemiología , Serogrupo , Streptococcus pneumoniae/clasificación
3.
Antimicrob Agents Chemother ; 57(11): 5239-46, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23939892

RESUMEN

In this surveillance study, we identified the genotypes, carbapenem resistance determinants, and structural variations of AbaR-type resistance islands among carbapenem-resistant Acinetobacter baumannii (CRAB) isolates from nine Asian locales. Clonal complex 92 (CC92), corresponding to global clone 2 (GC2), was the most prevalent in most Asian locales (83/108 isolates; 76.9%). CC108, or GC1, was a predominant clone in India. OXA-23 oxacillinase was detected in CRAB isolates from most Asian locales except Taiwan. blaOXA-24 was found in CRAB isolates from Taiwan. AbaR4-type resistance islands, which were divided into six subtypes, were identified in most CRAB isolates investigated. Five isolates from India, Malaysia, Singapore, and Hong Kong contained AbaR3-type resistance islands. Of these, three isolates harbored both AbaR3- and AbaR4-type resistance islands simultaneously. In this study, GC2 was revealed as a prevalent clone in most Asian locales, with the AbaR4-type resistance island predominant, with diverse variants. The significance of this study lies in identifying the spread of global clones of carbapenem-resistant A. baumannii in Asia.


Asunto(s)
Infecciones por Acinetobacter/epidemiología , Acinetobacter baumannii/genética , Antibacterianos/farmacología , Carbapenémicos/farmacología , Elementos Transponibles de ADN , Resistencia betalactámica/genética , Infecciones por Acinetobacter/tratamiento farmacológico , Infecciones por Acinetobacter/microbiología , Acinetobacter baumannii/clasificación , Acinetobacter baumannii/enzimología , Acinetobacter baumannii/aislamiento & purificación , Asia/epidemiología , Células Clonales , Monitoreo Epidemiológico , Expresión Génica , Humanos , Filogenia , Prevalencia , Resistencia betalactámica/efectos de los fármacos , beta-Lactamasas/genética , beta-Lactamasas/metabolismo
4.
J Antimicrob Chemother ; 68(12): 2820-4, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23843299

RESUMEN

OBJECTIVES: To investigate the epidemiological traits of metallo-ß-lactamase (MBL)-producing Pseudomonas aeruginosa (MPPA) clinical isolates collected by the Asian Network for Surveillance of Resistant Pathogens (ANSORP). METHODS: A total of 16 MPPA clinical isolates were collected from six Asian countries in 2000 to 2009 by ANSORP. The MBL gene was detected by PCR amplification. The genetic organization of the class 1 integron carrying the MBL gene cassette was investigated by PCR mapping and sequencing. Southern blotting, repetitive sequence-based PCR and multilocus sequence typing (MLST) experiments were performed to characterize the isolates. RESULTS: PCR and sequencing experiments detected the blaVIM-2 (n = 12), blaVIM-3 (n = 1), blaIMP-6 (n = 2) and blaIMP-26 (n = 1) genes. The MBL genes were located on the chromosome in all isolates except one. Furthermore, all the MBL genes were located in a class 1 integron. All the MPPA isolates from Malaysia, Thailand, Sri Lanka and Korea were identified as sequence type (ST) 235 by MLST. Three VIM-2-producing isolates from India were identified as ST773, and one isolate harbouring VIM-3 from Taiwan was identified as ST298. CONCLUSIONS: P. aeruginosa ST235 might play a role in dissemination of MBL genes in Asian countries.


Asunto(s)
Tipificación Molecular , Infecciones por Pseudomonas/epidemiología , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/clasificación , Pseudomonas aeruginosa/enzimología , beta-Lactamasas/metabolismo , Asia/epidemiología , Southern Blotting , ADN Bacteriano/química , ADN Bacteriano/genética , Genotipo , Humanos , Epidemiología Molecular , Reacción en Cadena de la Polimerasa , Infecciones por Pseudomonas/transmisión , Pseudomonas aeruginosa/genética , Pseudomonas aeruginosa/aislamiento & purificación , Análisis de Secuencia de ADN , beta-Lactamasas/genética
5.
J Clin Epidemiol ; 66(1): 44-51, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22542022

RESUMEN

OBJECTIVES: The present study evaluates the feasibility of rapid surveillance of community antimicrobial resistance (AMR) patterns of Streptococcus pneumoniae and Haemophilus influenzae in India using nasopharyngeal swabs (NPSs) of school children. It compares the AMR data obtained with that of invasive and nasopharyngeal (NP) isolates studied previously. No one has done such surveillance since our study so we decided to publish and more clearly demonstrate the feasibility of the methodology we did. STUDY DESIGN AND SETTING: This community-based, cross-sectional, cluster sample study had seven centers; each had two sites distant to them. Two hundred sixty school children per center were enrolled. NP swabbing was performed and isolates identified as S. pneumoniae and H. influenzae at each center were sent to reference laboratories. RESULTS: From January to December 2004, 1,988 NP swabs were processed; 776 S. pneumoniae and 64 H. influenzae were isolated. The AMR patterns for S. pneumoniae to co-trimoxazole varied, with sensitivity as low as 6% in Mumbai, 29% in Chennai and Vellore, and 100% in Delhi and Lucknow. For H. influenzae, sensitivity rates to co-trimoxazole ranged from 22% to 62%. The AMR patterns for both bacteria in the present study with data from invasive and NP isolates studied earlier were similar. CONCLUSION: The study demonstrates that it is practical and feasible to rapidly assess the AMR patterns of both S. pneumoniae and H. influenzae in NPSs of school children in different geographic locations all over India.


Asunto(s)
Farmacorresistencia Bacteriana , Haemophilus influenzae/efectos de los fármacos , Nasofaringe/microbiología , Streptococcus pneumoniae/efectos de los fármacos , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Niño , Análisis por Conglomerados , Estudios Transversales , Infecciones por Haemophilus/tratamiento farmacológico , Infecciones por Haemophilus/microbiología , Humanos , India/epidemiología , Pruebas de Sensibilidad Microbiana , Infecciones Neumocócicas/tratamiento farmacológico , Infecciones Neumocócicas/microbiología , Vigilancia de la Población/métodos , Combinación Trimetoprim y Sulfametoxazol/farmacología , Combinación Trimetoprim y Sulfametoxazol/uso terapéutico
6.
Antimicrob Agents Chemother ; 56(3): 1418-26, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22232285

RESUMEN

Antimicrobial resistance in Streptococcus pneumoniae remains a serious concern worldwide, particularly in Asian countries, despite the introduction of heptavalent pneumococcal conjugate vaccine (PCV7). The Asian Network for Surveillance of Resistant Pathogens (ANSORP) performed a prospective surveillance study of 2,184 S. pneumoniae isolates collected from patients with pneumococcal infections from 60 hospitals in 11 Asian countries from 2008 to 2009. Among nonmeningeal isolates, the prevalence rate of penicillin-nonsusceptible pneumococci (MIC, ≥ 4 µg/ml) was 4.6% and penicillin resistance (MIC, ≥ 8 µg/ml) was extremely rare (0.7%). Resistance to erythromycin was very prevalent in the region (72.7%); the highest rates were in China (96.4%), Taiwan (84.9%), and Vietnam (80.7%). Multidrug resistance (MDR) was observed in 59.3% of isolates from Asian countries. Major serotypes were 19F (23.5%), 23F (10.0%), 19A (8.2%), 14 (7.3%), and 6B (7.3%). Overall, 52.5% of isolates showed PCV7 serotypes, ranging from 16.1% in Philippines to 75.1% in Vietnam. Serotypes 19A (8.2%), 3 (6.2%), and 6A (4.2%) were the most prominent non-PCV7 serotypes in the Asian region. Among isolates with serotype 19A, 86.0% and 79.8% showed erythromycin resistance and MDR, respectively. The most remarkable findings about the epidemiology of S. pneumoniae in Asian countries after the introduction of PCV7 were the high prevalence of macrolide resistance and MDR and distinctive increases in serotype 19A.


Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana , Infecciones Neumocócicas/microbiología , Streptococcus pneumoniae/efectos de los fármacos , Asia , Farmacorresistencia Bacteriana Múltiple , Vacuna Neumocócica Conjugada Heptavalente , Humanos , Pruebas de Sensibilidad Microbiana , Resistencia a las Penicilinas , Infecciones Neumocócicas/prevención & control , Vacunas Neumococicas , Estudios Prospectivos , Serotipificación , Streptococcus pneumoniae/aislamiento & purificación , Vacunación
7.
Am J Respir Crit Care Med ; 184(12): 1409-17, 2011 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-21920919

RESUMEN

RATIONALE: Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) remain important causes of morbidity and mortality. Increasing antimicrobial resistance has aroused the concern of the failure of antibiotic treatment. OBJECTIVES: To determine the distribution of the bacterial isolates of HAP and VAP, their antimicrobial resistance patterns, and impact of discordant antibiotic therapy on clinical outcome in Asian countries METHODS: A prospective surveillance study was conducted in 73 hospitals in 10 Asian countries from 2008-2009. A total of 2,554 cases with HAP or VAP in adults were enrolled and 2,445 bacterial isolates were collected from 1,897 cases. Clinical characteristics and antimicrobial resistance profiles were analyzed. MEASUREMENT AND MAIN RESULTS: Major bacterial isolates from HAP and VAP cases in Asian countries were Acinetobacter spp., Pseudomonas aeruginosa, Staphylococcus aureus, and Klebsiella pneumoniae. Imipenem resistance rates of Acinetobacter and P. aeruginosa were 67.3% and 27.2%, respectively. Multidrug-resistant rates were 82% and 42.8%, and extensively drug-resistant rates were 51.1% and 4.9%. Multidrug-resistant rate of K. pneumoniae was 44.7%. Oxacillin resistance rate of S. aureus was 82.1%. All-cause mortality rate was 38.9%. Discordant initial empirical antimicrobial therapy increased the likelihood of pneumonia-related mortality (odds ratio, 1.542; 95% confidence interval, 1.127-2.110). CONCLUSIONS: Acinetobacter spp., P. aeruginosa, S. aureus, and K. pneumoniae are the most frequent isolates from adults with HAP or VAP in Asian countries. These isolates are highly resistant to major antimicrobial agents, which could limit the therapeutic options in the clinical practice. Discordant initial empirical antimicrobial therapy significantly increases the likelihood of pneumonia-related mortality.


Asunto(s)
Infección Hospitalaria/epidemiología , Farmacorresistencia Bacteriana Múltiple , Neumonía Bacteriana/epidemiología , Acinetobacter , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacología , Asia/epidemiología , Comorbilidad , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/microbiología , Infección Hospitalaria/mortalidad , Femenino , Humanos , Klebsiella pneumoniae , Masculino , Persona de Mediana Edad , Análisis Multivariante , Neumonía Bacteriana/tratamiento farmacológico , Neumonía Bacteriana/microbiología , Neumonía Bacteriana/mortalidad , Neumonía Asociada al Ventilador/tratamiento farmacológico , Neumonía Asociada al Ventilador/epidemiología , Neumonía Asociada al Ventilador/microbiología , Neumonía Asociada al Ventilador/mortalidad , Prevalencia , Estudios Prospectivos , Pseudomonas aeruginosa , Factores de Riesgo
8.
J Antimicrob Chemother ; 66(5): 1061-9, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21393157

RESUMEN

OBJECTIVES: Methicillin-resistant Staphylococcus aureus (MRSA) is highly prevalent in hospitals in many Asian countries. Recent emergence of community-associated (CA) MRSA worldwide has added another serious concern to the epidemiology of S. aureus infections. To understand the changing epidemiology of S. aureus infections in Asian countries, we performed a prospective, multinational surveillance study with molecular typing analysis. METHODS: We evaluated the prevalence of methicillin resistance in S. aureus isolates in CA and healthcare-associated (HA) infections, and performed molecular characterization and antimicrobial susceptibility tests of MRSA isolates. RESULTS: MRSA accounted for 25.5% of CA S. aureus infections and 67.4% of HA infections. Predominant clones of CA-MRSA isolates were ST59-MRSA-SCCmec type IV-spa type t437, ST30-MRSA-SCCmec type IV-spa type t019 and ST72-MRSA-SCCmec type IV-spa type t324. Previously established nosocomial MRSA strains including sequence type (ST) 239 and ST5 clones were found among CA-MRSA isolates from patients without any risk factors for HA-MRSA infection. CA-MRSA clones such as ST59, ST30 and ST72 were also isolated from patients with HA infections. CONCLUSIONS: Our findings confirmed that MRSA infections in the community have been increasing in Asian countries. Data also suggest that various MRSA clones have spread between the community and hospitals as well as between countries.


Asunto(s)
Infecciones Comunitarias Adquiridas/epidemiología , Infección Hospitalaria/epidemiología , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Infecciones Estafilocócicas/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Asia/epidemiología , Técnicas de Tipificación Bacteriana , Niño , Preescolar , Infecciones Comunitarias Adquiridas/microbiología , Infecciones Comunitarias Adquiridas/transmisión , Infección Hospitalaria/microbiología , Infección Hospitalaria/transmisión , Femenino , Humanos , Lactante , Cooperación Internacional , Masculino , Persona de Mediana Edad , Epidemiología Molecular , Tipificación Molecular , Prevalencia , Estudios Prospectivos , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/transmisión , Adulto Joven
9.
Saudi J Kidney Dis Transpl ; 21(5): 876-80, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20814124

RESUMEN

We studied the incidence and the risk factors predisposing to post transplantation urinary tract infection (UTI) and the association with use of different immunosuppressive regimens. We performed a retrospective analysis of 152 recipients of renal transplantation over a period of two years. Seventy one (46.71%) patients had culture positive UTI, Escherichia coli (45.1%) being the commonest. Thirty four (22.39%) patients had acute rejection and 14.4% of those had suffered UTI in the early post transplant period. Immunosuppression included induction with various antibodies and maintenance on antirejection medications. Trimethoprim-sulphamethoxazole was given as prophylaxis throughout the period. The UTI was treated according to microbiological sensitivity. 2.8% died due to urosepsis. In our retrospective analysis renal transplant recipients under the age of 45, female gender and diabetics suffered more UTI. Combination therapy with micro-emulsion form of cyclosporine A, prednisolone and azathioprine developed more UTI (P= 0.0418).


Asunto(s)
Inmunosupresores/efectos adversos , Trasplante de Riñón/efectos adversos , Infecciones Urinarias/etiología , Adulto , Factores de Edad , Antibacterianos/uso terapéutico , Profilaxis Antibiótica , Distribución de Chi-Cuadrado , Diabetes Mellitus/epidemiología , Quimioterapia Combinada , Femenino , Rechazo de Injerto/etiología , Rechazo de Injerto/prevención & control , Humanos , Incidencia , India/epidemiología , Trasplante de Riñón/mortalidad , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Factores Sexuales , Resultado del Tratamiento , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiología , Infecciones Urinarias/mortalidad , Infecciones Urinarias/prevención & control
10.
J Infect ; 61(4): 299-306, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20670652

RESUMEN

OBJECTIVE: This study was conducted to identify the predictors of mortality and to evaluate the impact of methicillin resistance on outcome in patients with Staphylococcus aureus infection according to underlying conditions and type of infection. METHODS: An observational cohort study including 4949 patients with S. aureus infection was conducted. We compared data from patients with MRSA infection with those with MSSA infection. RESULTS: The 30-day mortality rate of MRSA group was significantly higher than that of MSSA group (15.6% vs. 6.2%, P < 0.001). However, MRSA infection was not found to be independent risk factor for mortality after adjusting for other variables (OR = 1.03, 95% CI = 0.80-1.32). When we analyzed patients with S. aureus bacteremia (n = 709), MRSA infection was found to be significantly associated with mortality in multivariate analysis (Adjusted OR = 1.69, 95% CI = 1.15-2.49). When the 30-day mortality rates were compared according to underlying diseases, the 30-day mortality rate of MRSA group was significantly higher than that of MSSA group in patients with malignancy or renal diseases. MRSA infection was also found to be one of the independent risk factors for mortality in patients with malignancy (adjusted OR = 1.69, 95% CI = 1.06-2.70) and in those with renal disease (adjusted OR = 1.70, 95% CI = 1.0-2.89), after adjustment for host variables. CONCLUSIONS: Methicillin resistance adversely affected the outcome of patients with S. aureus infection, in patients with cancer or renal disease and in those with S. aureus bacteremia, although MRSA infection was not found to be significantly associated with higher mortality in overall patient population.


Asunto(s)
Antibacterianos/uso terapéutico , Resistencia a la Meticilina , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Infecciones Estafilocócicas/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacología , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Bacteriemia/mortalidad , Niño , Preescolar , Estudios de Cohortes , Femenino , Humanos , Lactante , Recién Nacido , Enfermedades Renales/complicaciones , Masculino , Persona de Mediana Edad , Neoplasias/complicaciones , Estudios Prospectivos , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/mortalidad , Resultado del Tratamiento , Adulto Joven
11.
Kathmandu Univ Med J (KUMJ) ; 8(30): 164-8, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21209528

RESUMEN

BACKGROUND: Invasive pneumococcal disease is a significant cause of morbidity and mortality worldwide and it is a major cause for childhood deaths in Nepal. OBJECTIVES: The aim of this study was to establish the antimicrobial susceptibility pattern of Streptococcus pneumoniae and perform serotype responsible for pneumococcal disease in Nepal. MATERIALS AND METHODS: All together 3774 children from 2 to 60 months who fulfilled the enrollment criteria for suspect of bacterial pneumonia, sepsis or meningitis were enrolled for etiologic studies of severe illness. During the study period 60 isolates of Streptococcus pneumoniae were isolated and the antimicrobial susceptibility testing and serotyping were performed. RESULTS: The study showed that 24 (52. 17%) isolates were resistant to Cotrimoxazole, 3 (6. 5%) isolates were intermediately resistant to Penicillin but no Penicillin resistant strains were isolated. The 1 (2. 17%) isolate was recorded as Erythromycin and Chloramphenicol resistant and only 1 (2. 17%) isolate was found intermediately resistant to Cefotaxime. Of the 60 isolates, serotyping result was available only for 46 isolates. The most common serotypes were serotype 1 (27. 65%) followed by serotype 5 (19. 14%) and serotype 4 (8. 5%) respectively followed by serotype 39, 23F, 7F, 19B, 12A, 14, 18F, 6B, 32, 16, 19F and 25F. CONCLUSIONS: Alarming level of Cotrimoxazole resistance demands revision of pneumonia treatment policy in Nepal and rising tendency of other drug resistance against Streptococcus pneumoniae showed use of these drugs for the treatment of meningitis, pneumonia and other serious infections needs extended research. The common serotype 1, 5 and 4 need to be incorporated in pneumococcal vaccine to immunise children in Nepal.


Asunto(s)
Infecciones Neumocócicas/microbiología , Streptococcus pneumoniae/clasificación , Streptococcus pneumoniae/efectos de los fármacos , Preescolar , Farmacorresistencia Bacteriana , Femenino , Humanos , Lactante , Masculino , Pruebas de Sensibilidad Microbiana , Nepal/epidemiología , Infecciones Neumocócicas/epidemiología , Prevalencia , Serotipificación , Streptococcus pneumoniae/aislamiento & purificación
12.
Pediatr Infect Dis J ; 28(8): 738-40, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19633518

RESUMEN

We assessed the effect of distribution of Haemophilus influenzae type b (Hib) vaccine in the private health care sector on Hib meningitis admissions at a referral hospital in India. The annual mean number of Hib cases was 10.7 before Hib vaccine introduction, falling to 3.8 cases following introduction (P < 0.0001). By contrast, the mean of annual numbers of pneumococcal cases were 3.0 and 4.6, (P = 0.55). Even at relatively low coverage through private sector distribution, Hib vaccine has significant community impact on Hib disease.


Asunto(s)
Vacunas contra Haemophilus/administración & dosificación , Haemophilus influenzae tipo b/inmunología , Meningitis por Haemophilus/epidemiología , Meningitis por Haemophilus/inmunología , Vacunas contra Haemophilus/inmunología , Humanos , India/epidemiología , Vacunación Masiva , Meningitis por Haemophilus/prevención & control , Meningitis Neumocócica/epidemiología , Meningitis Neumocócica/inmunología , Meningitis Neumocócica/prevención & control , Distribución de Poisson , Vigilancia de la Población , Estudios Prospectivos , Análisis de Regresión , Streptococcus pneumoniae/inmunología
13.
Clin Infect Dis ; 48 Suppl 2: S123-8, 2009 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-19191607

RESUMEN

BACKGROUND: Pneumonia accounts for approximately 2 million deaths annually among children aged <5 years, with most of these deaths occurring in Africa and southern Asia. The South Asian Pneumococcal Alliance (SAPNA) network in Nepal is generating local epidemiological data to assist in the development of national and regional policies for prevention of pneumococcal and Haemophilus influenzae (Hib) disease. METHODS: Children aged 2 months to 5 years with suspected invasive bacterial disease were recruited from Kanti Children Hospital, Kathmandu, Nepal. Specimens of blood, CSF, and normally sterile body fluids were cultured, and analysis of antimicrobial susceptibility patterns and serotyping of Streptococcus pneumoniae isolates were performed. CSF specimens were also tested for S. pneumoniae and Hib antigens by a latex agglutination test and an immunochromatographic test of pneumococcal antigen (NOW S. pneumoniae Antigen Test; Binax). RESULTS: A total of 2528 children with suspected invasive bacterial disease were recruited, of whom 82% had pneumonia, 9.6% had meningitis, 2% had very severe disease, and 0.4% had bacteremia; the remainder received another diagnosis. Before hospitalization, 26.7% had received antibiotic treatment. Fifty children had S. pneumoniae identified as the etiological agent of invasive disease. Of 2461 blood cultures performed, 22 were positive for S. pneumoniae. Of 33 cases of S. pneumoniae meningitis, 11 were detected by CSF culture, and 21 were detected by latex agglutination and pneumococcal antigen tests. The rate of detection of S. pneumoniae in CSF was 3.6% by culture, compared with 7.8% by latex agglutination and 10% by pneumococcal antigen testing. The rate of detection of H. influenzae in CSF was 1.7% by culture and 6.5% by latex agglutination. The most common serotypes found were 1, 5, 2, and 7F, followed by 12A, 19B, and 23F. Of all the invasive isolates, 3.8% were resistant to penicillin, and 68% were resistant to trimethoprim-sulfamethoxazole. CONCLUSIONS: The SAPNA network has identified Hib and pneumococci as causes of significant disease in Nepal.


Asunto(s)
Infecciones Neumocócicas/epidemiología , Streptococcus pneumoniae/aislamiento & purificación , Antibacterianos/farmacología , Antígenos Bacterianos/líquido cefalorraquídeo , Bacteriemia/epidemiología , Bacteriemia/microbiología , Sangre/microbiología , Líquido Cefalorraquídeo/microbiología , Niño Hospitalizado , Preescolar , Cromatografía de Afinidad , Farmacorresistencia Bacteriana , Humanos , Lactante , Recién Nacido , Pruebas de Fijación de Látex , Meningitis Neumocócica/epidemiología , Pruebas de Sensibilidad Microbiana , Nepal/epidemiología , Neumonía Neumocócica/epidemiología , Prevalencia , Serotipificación , Streptococcus pneumoniae/clasificación
14.
Clin Infect Dis ; 48 Suppl 2: S136-40, 2009 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-19191609

RESUMEN

The South Asian Pneumococcal Surveillance network uses standard recruitment and laboratory procedures for surveillance of invasive pneumococcal disease in India, Nepal, and Sri Lanka. Children aged 2 months to 5 years who were admitted to the sentinel surveillance site, Lady Ridgeway Hospital for Children, in Colombo, Sri Lanka, and who presented with signs and symptoms of meningitis, pneumonia, or very severe disease were studied. Blood culture and CSF culture specimens were analyzed at the microbiology laboratory at Lady Ridgeway Hospital for Children. Specimens were processed by routine conventional methods. Antigen testing was performed on CSF specimens with use of commercially available latex agglutination test kits. From January 2005 to March 2007, we observed 23 isolates of Streptococcus pneumoniae, and the most common serotypes were 19F, 14, 23F, and 6B. Of the serotypes found, 60% are covered by the currently available 7-valent conjugate pneumococcal vaccine. More than 90% of the isolates were penicillin resistant, and the rate of resistance to third-generation cephalosporins was also high.


Asunto(s)
Infecciones Neumocócicas/epidemiología , Streptococcus pneumoniae/aislamiento & purificación , Antibacterianos/farmacología , Antígenos Bacterianos/líquido cefalorraquídeo , Bacteriemia/epidemiología , Bacteriemia/microbiología , Técnicas de Tipificación Bacteriana , Sangre/microbiología , Líquido Cefalorraquídeo/microbiología , Niño Hospitalizado , Preescolar , Hospitales , Humanos , Incidencia , Lactante , Pruebas de Fijación de Látex , Meningitis Neumocócica/epidemiología , Neumonía Neumocócica/epidemiología , Serotipificación , Sri Lanka/epidemiología , Streptococcus pneumoniae/clasificación , Resistencia betalactámica , beta-Lactamas/farmacología
15.
Indian J Med Res ; 128(1): 57-64, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18820360

RESUMEN

BACKGROUND & OBJECTIVE: Vaccine policy depends on locally relevant disease burden estimates. The incidence of Haemophilus influenzae type b (Hib) disease is not well characterized in the South Asian region, home to 30 per cent of the world's children. There are limited data from prospective population incidence studies of Hib in Asia, and no data available from India. We therefore carried out this study to assess the burden of Hib meningitis in India. METHODS: A prospective surveillance study was carried out during 1997 and 1999 in hospitals for cases of Hib meningitis from 5 administrative areas of an Indian district (Vellore, Tamil Nadu) with 56,153 children under 5 yr of age, over a 24 month period RESULTS: Ninety seven cases of possible meningitis (> 10 WBC/microl in CSF) were reported, an annual incidence of 86 per 100,000 (95%CI 69 to 109) in 0-4 yr old children, and 357 per 100,000 in 0-11 month infants. Eighteen had proven bacterial meningitis, an annual incidence of 15.9 per 100,000. Eight CSF had Hib by culture or antigen testing, an annual incidence of 7.1 per 100,000 (95%CI 3.1 to 14.0) in children 0-59 months. In infants 0-11 months of age, the incidence of Hib meningitis was 32 per 100,000 (95%CI 16 to 67) and in the 0-23 month group it was 19 (95%CI 8 to 37). INTERPRETATION & CONCLUSION: Our data are the first minimal estimate of the incidence of Hib meningitis for Indian children. The observed incidence data are similar to European reports before Hib vaccine use, suggest substantial disease before 24 months of age, and provide data useful for policy regarding Hib immunization.


Asunto(s)
Vacunas contra Haemophilus , Haemophilus influenzae tipo b , Meningitis por Haemophilus/epidemiología , Meningitis por Haemophilus/prevención & control , Preescolar , Humanos , Incidencia , India/epidemiología , Lactante
16.
Indian J Med Res ; 127(1): 78-84, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18316857

RESUMEN

BACKGROUND & OBJECTIVE: Conventional methods to detect methicillin resistance in Staphylococcus aureus are inadequate as expression of resistance is subject to environmental and conditional expression of PBP2a antigen. The objective of the present study was to determine methicillin resistance in S. aureus by conventional susceptibility (oxacillin disc diffusion and oxacillin MIC) and molecular methods (PCR) and to evaluate latex agglutination test for the detection of PBP 2a and to compare the results of these tests for its sensitivity, specificity and rapidity. METHODS: A total of 150 consecutive clinical isolates of Staphylococcus aureus received at the Department of Microbiology, Christian Medical College, Vellore, were included. Oxacillin (1 mg) disc diffusion and agar dilution method were used. The isolates were also subjected to latex agglutination test for detection of PBP2a and multiplex PCR to detect mecA and femB genes. RESULTS: Of the 150 isolates, 33 were found to be MRSA by oxacillin disc diffusion. By MIC method, 13 per cent of the isolates had values 32 microg/ml, 6 per cent between 16-8 mug/ml and 2.7 per cent had a value of 4 microg/ml; 100 per cent concordance was obtained between the oxacillin disc screening and MIC methods. The latex agglutination showed positive reaction for all MRSA with only one MSSA being falsely classified as MRSA. The specificity and sensitivity were 99 and 100 per cent respectively. Test results were obtained within 15 min. By multiplex PCR, all 22 per cent of MRSA were positive for mecA and femB genes and additionally one MSSA carried mecA gene. However, femB gene was not found in 6 MSSA isolates. Specificity and sensitivity of PCR for mecA detection was similar to latex agglutination test. PCR system required approximately five hours. INTERPRETATION & CONCLUSION: Our findings showed that the conventional methods for detection of methicillin resistance like disc screening, disc diffusion and MIC are cost-effective but time consuming. Latex agglutination though expensive is rapid and can be a good preliminary screen with high sensitivity and specificity. Multiplex PCR is a good confirmatory test though expensive.


Asunto(s)
Resistencia a la Meticilina , Staphylococcus aureus/efectos de los fármacos , Pruebas de Aglutinación , Genotipo , Humanos , Pruebas de Sensibilidad Microbiana , Fenotipo , Reacción en Cadena de la Polimerasa , Staphylococcus aureus/clasificación , Staphylococcus aureus/genética
17.
Int J Antimicrob Agents ; 31(2): 107-14, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18162378

RESUMEN

Appropriate antimicrobial treatment of community-acquired pneumonia (CAP) should be based on the distribution of aetiological pathogens, antimicrobial resistance of major pathogens, clinical characteristics and outcomes. We performed a prospective observational study of 955 cases of adult CAP in 14 hospitals in eight Asian countries. Microbiological evaluation to determine etiological pathogens as well as clinical evaluation was performed. Bronchopulmonary disease (29.9%) was the most frequent underlying disease, followed by cardiovascular diseases (19.9%), malignancy (11.7%) and neurological disorder (8.2%). Streptococcus pneumoniae (29.2%) was the most common isolate, followed by Klebsiella pneumoniae (15.4%) and Haemophilus influenzae (15.1%). Serological tests were positive for Mycoplasma pneumoniae (11.0%) and Chlamydia pneumoniae (13.4%). Only 1.1% was positive for Legionella pneumophila by urinary antigen test. Of the pneumococcal isolates, 56.1% were resistant to erythromycin and 52.6% were not susceptible to penicillin. Seventeen percent of CAP had mixed infection, especially S. pneumoniae with C. pneumoniae. The overall mortality rate was 7.3%, and nursing home residence, mechanical ventilation, malignancy, cardiovascular diseases, respiratory rate>30/min and hyponatraemia were significant independent risk factors for mortality by multivariate analysis (P<0.05). The current data provide relevant information about pathogen distribution and antimicrobial resistance of major pathogens of CAP as well as clinical outcomes of illness in Asian countries.


Asunto(s)
Antígenos Bacterianos/inmunología , Infecciones Comunitarias Adquiridas/diagnóstico , Infecciones Comunitarias Adquiridas/epidemiología , Neumonía Bacteriana/diagnóstico , Vigilancia de la Población/métodos , Streptococcus pneumoniae/efectos de los fármacos , Adulto , Antibacterianos/uso terapéutico , Asia/epidemiología , Infecciones Comunitarias Adquiridas/microbiología , Infecciones Comunitarias Adquiridas/mortalidad , Estudios Epidemiológicos , Humanos , Legionella pneumophila/genética , Legionella pneumophila/inmunología , Legionella pneumophila/aislamiento & purificación , Neumonía Bacteriana/tratamiento farmacológico , Neumonía Bacteriana/microbiología , Neumonía Neumocócica/diagnóstico , Estudios Prospectivos , Streptococcus pneumoniae/aislamiento & purificación , Streptococcus pneumoniae/metabolismo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...